Autumn Research Update Meeting 2025
Our 2025 Autumn Research Update Meeting will take place once again at the renowned Royal Society of Medicine (RSM), Wimpole Street, London, on Monday 10 November, where guests can look forward to an engaging agenda featuring the latest updates from our funded research. Theme: Revolutionising...
Learn more
A triathlon challenge for tri-ing times!
Cure Parkinson’s would like to say a huge thank you to supporters Georgie and Matt (pictured below), who completed their incredible challenge of running, cycling and swimming the equivalent 1,350km distance from John O’Groats to Calais around their local area from the 29 May –…
The Ricky Road Run goes virtual for 2020!
From Friday 17 July – Monday 3 August, 30 running enthusiasts took part in the ‘virtual’ Ricky Road Run in support of Cure Parkinson’s pioneering Parkinson’s research. Due to COVID 19 restrictions, the Ricky Road Run which takes place annually around Rickmansworth and Chorleywood in…
A cycle challenge turns virtual for Parkinson’s research
This summer supporters Vivienne & Alec Armitage along with a team of family and friends including their daughter and son in law Rosie and Peter Ward were due to take on the iconic Land’s End to John O’Groats cycle challenge in support of Cure Parkinson’s….
Further support for GLP-1R agonists
Glucagon-like peptide 1 receptor (or GLP-1R) agonists are a frontline treatment for diabetes – improving glycaemic control by reducing glucose concentrations in the blood. In 2008, multiple research groups reported that this class of drugs exhibited neuroprotective properties in models of Parkinson’s. Subsequent clinical trials have provided encouraging data supporting this […]
Further support for GLP-1R agonists
Glucagon-like peptide 1 receptor (or GLP-1R) agonists are a frontline treatment for diabetes – improving glycaemic control by reducing glucose concentrations in the blood. In 2008, multiple research groups reported that this class of drugs exhibited neuroprotective properties in models of Parkinson’s. Subsequent clinical trials have provided encouraging data supporting this […]